All treatments
Treatment
Ozanimod, Ozanimod clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
This study is testing a new medicine, Ozanimod, for people in the UK with moderate to severe ulcerative colitis. It's looking at how well the medicine helps control symptoms and improve the gut, as well as checking for any side effects. It's a key stage of testing before being widely available.
For: Ulcerative colitisBelgium · Romania · Poland - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
This study is looking at a medicine called ozanimod for people with Crohn's disease that is moderate to severe. It wants to see how well the medicine helps reduce their symptoms and improve their gut health over a long period. Researchers will also check how it affects COVID-19 antibody levels.
For: Moderately to Severely Active Crohn's DiseaseGermany · Hungary · Slovakia